Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of γ-tocotrienol in neoplastic mammary epithelial cells

被引:42
作者
Sylvester, PW [1 ]
Shah, SJ [1 ]
Samant, GV [1 ]
机构
[1] Univ Louisiana Monroe, Sch Pharm, Monroe, LA 71209 USA
关键词
Akt; apoptosis; caspase; FLIP; mammary cancer; PI3K; tocotrienol; vitamin E;
D O I
10.1016/j.jplph.2005.04.014
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Tocotrienols, a subgroup within the vitamin E family of compounds, display potent anti proliferative and apoptotic activity against neoplastic mammary epithelial cells at treatment doses that have little or no effect on normal cell growth and function. Recent studies have shown that treatment with a growth inhibitory, but non-cytotoxic dose (4 mu M) of gamma-tocotrienol inhibits phosphatidylinositol-3-kinase-dependent kinase (PI3K)/PI3K-dependent kinase 1 (PDK-1)/mitogenic signaling over a 2-3 day period following treatment exposure, and these effects were not found to be associated with an increased in either phosphatase and tensin homologue deleted from chromosome 10 (PTEN) or protein phosphatase type 2A (PP2A) phosphatase activity. In addition, this treatment caused a Large decrease in NF kappa B transcriptional activity, apparently by suppressing I kappa B-kinase (IKK)-alpha/beta activation, an enzyme associated with inducing NF kappa B activation. Since Akt and NF kappa B are intimately involved in mammary tumor cell proliferation and survival, these findings strongly suggest that the anti proliferative effects of gamma-tocotrienol result, at least in part, from a reduction in Akt and NF kappa B activity. In contrast, treatment with 20 mu M gamma-tocotrienol (cytotoxic dose) resulted in caspase-8 and -3 activation and apoptosis. It was also shown that this same treatment caused a rapid and large decrease in PI3K/PDK/Akt signaling within 2-4h following treatment exposure, and a corresponding decrease in intracellular levels of FLIP, an antiapoptotic protein that inhibits caspase-8 activation. In summary, both the antiproliferative and apoptotic effects of gamma-tocotrienol appear to be mediated by a reduction in the PI3K/PDK-1/Akt signaling, an important pathway associated with cell proliferation and survival in neoplastic mammary epithelial cells. (c) 2005 Elsevier GmbH. All rights reserved.
引用
收藏
页码:803 / 810
页数:8
相关论文
共 24 条
[1]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[2]   Epidermal growth factor-induced nuclear factor κB activation:: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells [J].
Biswas, DK ;
Cruz, AP ;
Gansberger, E ;
Pardee, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) :8542-8547
[3]   NUTRITIONAL ASPECTS OF PALM OIL - INTRODUCTION [J].
COTTRELL, RC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 53 (04) :S989-S1009
[4]  
DANIELSON KG, 1980, CANCER RES, V40, P1812
[5]   Mechanisms and consequences of activation of protein kinase B/Akt [J].
Downward, J .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) :262-267
[6]   ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth [J].
Hermanto, U ;
Zong, CS ;
Wang, LH .
ONCOGENE, 2001, 20 (51) :7551-7562
[7]  
Hughes SJ, 1997, CANCER RES, V57, P5571
[8]   The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB [J].
Kandel, ES ;
Hay, N .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :210-229
[9]   Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells [J].
McIntyre, BS ;
Briski, KP ;
Gapor, A ;
Sylvester, PW .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 224 (04) :292-301
[10]   Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells [J].
McIntyre, BS ;
Briski, KP ;
Tirmenstein, MA ;
Fariss, MW ;
Gapor, A ;
Sylvester, PW .
LIPIDS, 2000, 35 (02) :171-180